These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28017391)

  • 61. Acute myocardial infarction associated with intravenous dipyridamole for rubidium-82 PET imaging.
    Marwick TH; Hollman J
    Clin Cardiol; 1990 Mar; 13(3):230-1. PubMed ID: 2323124
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Attenuation correction for stress and rest PET 82Rb myocardial perfusion images.
    Eisner RL; Patterson RE
    J Nucl Med; 2007 Nov; 48(11):1912-3; author reply 1913-4. PubMed ID: 17978359
    [No Abstract]   [Full Text] [Related]  

  • 63. Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease.
    Sampson UK; Dorbala S; Limaye A; Kwong R; Di Carli MF
    J Am Coll Cardiol; 2007 Mar; 49(10):1052-8. PubMed ID: 17349884
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Rubidium-82 cardiac positron emission tomography imaging: an overview for the general cardiologist.
    Dhar R; Ananthasubramaniam K
    Cardiol Rev; 2011; 19(5):255-63. PubMed ID: 21808169
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The Difficulty of Determining Disease Activity in Large Artery Vasculitis.
    Olin JW; Narula N
    JACC Cardiovasc Imaging; 2017 Sep; 10(9):1053-1055. PubMed ID: 28109926
    [No Abstract]   [Full Text] [Related]  

  • 66. Assessing coronary sinus blood flow in patients with coronary artery disease: a comparison of phase-contrast MR imaging with positron emission tomography.
    Koskenvuo JW; Hartiala JJ; Knuuti J; Sakuma H; Toikka JO; Komu M; Saraste M; Niemi P
    AJR Am J Roentgenol; 2001 Nov; 177(5):1161-6. PubMed ID: 11641194
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Myocardial perfusion scintigraphy using rubidium-82 positron emission tomography.
    Arumugam P; Tout D; Tonge C
    Br Med Bull; 2013; 107():87-100. PubMed ID: 23966422
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Precision and accuracy of clinical quantification of myocardial blood flow by dynamic PET: A technical perspective.
    Moody JB; Lee BC; Corbett JR; Ficaro EP; Murthy VL
    J Nucl Cardiol; 2015 Oct; 22(5):935-51. PubMed ID: 25868451
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Low-dose 3D (82)Rb PET.
    Slomka PJ; Berman DS; Germano G
    J Nucl Cardiol; 2012 Dec; 19(6):1110-2. PubMed ID: 23129187
    [No Abstract]   [Full Text] [Related]  

  • 70. False-positive stress PET-CT imaging in a patient with interstitial injection.
    Erthal L; Erthal F; Beanlands RSB; Ruddy TD; deKemp RA; Dwivedi G
    J Nucl Cardiol; 2017 Aug; 24(4):1447-1450. PubMed ID: 27519643
    [No Abstract]   [Full Text] [Related]  

  • 71. Clinical cardiac PET using generator-produced Rb-82: a review.
    Gould KL
    Cardiovasc Intervent Radiol; 1989; 12(5):245-51. PubMed ID: 2514984
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Should patients hold proton pump inhibitors prior to
    Al-Mallah MH
    J Nucl Cardiol; 2020 Oct; 27(5):1452-1455. PubMed ID: 32095936
    [No Abstract]   [Full Text] [Related]  

  • 73. Revival of an old stressor: Dobutamine-stimulation for PET myocardial perfusion imaging in patients with end-stage liver disease?
    Schindler TH; Leucker T
    J Nucl Cardiol; 2020 Dec; 27(6):2060-2062. PubMed ID: 30515744
    [No Abstract]   [Full Text] [Related]  

  • 74. Myocardial blood flow quantification by Rb-82 cardiac PET/CT: Methodological issues on reproducibility study.
    Sabour S
    J Nucl Cardiol; 2017 Oct; 24(5):1831. PubMed ID: 27600914
    [No Abstract]   [Full Text] [Related]  

  • 75. Moving towards a better understanding of potential pitfalls in quantitative PET myocardial blood flow.
    Cremer PC; DiFilippo FP; Jaber WA
    J Nucl Cardiol; 2018 Aug; 25(4):1296-1298. PubMed ID: 28229361
    [No Abstract]   [Full Text] [Related]  

  • 76. Status of cardiovascular PET radiation exposure and strategies for reduction: An Information Statement from the Cardiovascular PET Task Force.
    Case JA; deKemp RA; Slomka PJ; Smith MF; Heller GV; Cerqueira MD
    J Nucl Cardiol; 2017 Aug; 24(4):1427-1439. PubMed ID: 28512722
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Striving to improve
    Rimoldi O
    J Nucl Cardiol; 2019 Dec; 26(6):1943-1945. PubMed ID: 30136035
    [No Abstract]   [Full Text] [Related]  

  • 78.
    Van Tosh A; Nichols KJ
    J Nucl Cardiol; 2022 Aug; 29(4):1643-1646. PubMed ID: 33748939
    [No Abstract]   [Full Text] [Related]  

  • 79. Accounting for residual activity in the estimate of myocardial blood flow with PET.
    Nye JA; Cooke CD
    J Nucl Cardiol; 2022 Oct; 29(5):2271-2273. PubMed ID: 34918236
    [No Abstract]   [Full Text] [Related]  

  • 80. Metastatic breast cancer diagnosed by rubidium-82 positron emission tomography myocardial perfusion imaging.
    Shafiq A; Ammar KA; Gilles L; Machernis N; Mahlum D; Chareonthaitawee P; Port SC
    J Nucl Cardiol; 2018 Jun; 25(3):1048-1050. PubMed ID: 28258558
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.